Endocrine oncology

Natural History and Predictive Factors of Outcome in Medullary Thyroid Microcarcinoma

J Clin Endocrinol MetabPublished Retrospective cohort study

Authors' conclusion

Most sporadic micro-MTCs are detected incidentally and are generally associated with good outcomes. Size is not significantly associated with outcomes. Using grade, LNM, and postoperative calcitonin allows for the identification of patients at risk of recurrence to personalize management.

Study context

Population
Patients with surgically managed sporadic medullary thyroid microcarcinoma <1 cm (micro-MTC), 1995–2022; median age 60 years, median tumour size 4 mm, 67% female; hereditary disease excluded22 hereditary excluded
Participants
64 patients
Outcome
Recurrence, time to recurrence and disease-specific survival
Methodological detailsprospectively maintained surgery database, single specialist endocrine surgery and endocrinology unit, pathology slide review
  • Prospectively maintained surgery database
  • Single specialist endocrine surgery and endocrinology unit
  • Pathology slide review

Main finding

As reported in the abstract

median follow-up 6.6 years
Developed recurrence
5 (12%)
Died of MTC
3 (7%)
10-year survival, high grade and lymph node metastasis (LNM) vs low grade and no LNM
75% vs 100% (HR = 831; P < .01)
High grade, LNM and increased calcitonin associated with recurrence
P < .01
Recurrence with low grade micro-MTC and normal postoperative calcitonin
0

Observational data: associations, not effects.

Further findings

Baseline characteristics

Incidental diagnosis
36 (86%)
High grade
4 (10%)
LNM
5 (12%)
Elevated postoperative calcitonin
9 (21%)

Original publication

Natural History and Predictive Factors of Outcome in Medullary Thyroid Microcarcinoma. J Clin Endocrinol Metab. Published 25 March 2023. doi:10.1210/clinem/dgad173

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.